ACUTA CAPITAL PARTNERS, LLC Hedge Fund

Location: Redwood City, CA

CIK: 0001582844 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 13, 2017

Total Value: $269M (96.1% shares, 3.9% debt)

Holdings (50)

VCYT VERACYTE INC 10.1%
Value $27.19M Shares 3,513,161 Est. Cost $7.18 Unrealized +4.1%
LION BIOTECHNOLOGIES INC 9.8%
Value $26.48M Shares 3,809,944 Est. Cost $7.90 Unrealized
IRIX IRIDEX CORP 8.1%
Value $21.85M Shares 1,554,146 Est. Cost $11.61 Unrealized +22.4%
IMMUNOMEDICS INC 6.4%
Value $17.25M Shares 4,700,000 Est. Cost $2.70 Unrealized
NEURODERM LTD 5.5%
Value $14.78M Shares 665,944 Est. Cost $17.76 Unrealized
EDGE THERAPEUTICS INC 4.8%
Value $13M Shares 1,040,265 Est. Cost $11.09 Unrealized
ASSEMBLY BIOSCIENCES INC 4.4%
Value $11.87M Shares 976,599 Est. Cost $10.18 Unrealized
ASND ASCENDIS PHARMA A S 4.3%
Value $11.64M Shares 575,309 Est. Cost $18.67 Unrealized
IMMUNOMEDICS INC 3.9%
Value $10.39M Shares 10,500,000 Est. Cost $0.81 Unrealized
ACRS ACLARIS THERAPEUTICS INC 3.8%
Value $10.12M Shares 372,753 Est. Cost $25.50 Unrealized 0.0%
IWM ISHARES TR 3.5%
Value $9.44M Shares 70,000 Est. Cost Unrealized
ACAD ACADIA PHARMACEUTICALS INC 3.2%
Value $8.652M Shares 300,000 Est. Cost $31.79 Unrealized -16.8%
CHEMBIO DIAGNOSTICS INC 2.9%
Value $7.826M Shares 1,150,925 Est. Cost $7.21 Unrealized
AKBA AKEBIA THERAPEUTICS INC 2.7%
Value $7.275M Shares 698,825 Est. Cost $8.35 Unrealized +3.1%
OXFORD IMMUNOTEC GLOBAL PLC 2.6%
Value $7.039M Shares 470,834 Est. Cost $12.00 Unrealized
MARVELL TECHNOLOGY GROUP LTD 2.6%
Value $6.935M Shares 500,000 Est. Cost $11.51 Unrealized
CAS MED SYS INC 2.5%
Value $6.73M Shares 4,179,838 Est. Cost $1.52 Unrealized
RA PHARMACEUTICALS INC 2.1%
Value $5.74M Shares 377,909 Est. Cost $15.19 Unrealized
GW PHARMACEUTICALS PLC 1.7%
Value $4.47M Shares 40,000 Est. Cost $132.74 Unrealized
NABRIVA THERAPEUTICS AG 1.6%
Value $4.21M Shares 706,383 Est. Cost $8.67 Unrealized
WEBMD HEALTH CORP 1.5%
Value $3.966M Shares 80,000 Est. Cost $51.92 Unrealized
DBV TECHNOLOGIES S A 1.2%
Value $3.228M Shares 91,898 Est. Cost $35.86 Unrealized
VCYT VERACYTE INC 1.1%
Value $2.903M Shares 375,000 Est. Cost $7.18 Unrealized +4.1%
DERMIRA INC 1.0%
Value $2.684M Shares 88,500 Est. Cost $29.25 Unrealized
VNDA VANDA PHARMACEUTICALS INC 1.0%
Value $2.593M Shares 162,600 Est. Cost $13.46 Unrealized +19.4%
RECRO PHARMA INC 0.9%
Value $2.418M Shares 300,000 Est. Cost $8.06 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 0.8%
Value $2.1M Shares 1,000,000 Est. Cost $3.22 Unrealized 0.0%
AERIE PHARMACEUTICALS INC 0.7%
Value $1.893M Shares 50,000 Est. Cost $37.74 Unrealized
CLEARSIDE BIOMEDICAL INC 0.6%
Value $1.565M Shares 175,000 Est. Cost $8.94 Unrealized
ZBH ZIMMER BIOMET HLDGS INC 0.6%
Value $1.548M Shares 15,000 Est. Cost $99.44 Unrealized 0.0%
SRPT SAREPTA THERAPEUTICS INC 0.5%
Value $1.372M Shares 50,000 Est. Cost $18.47 Unrealized +117.5%
ESSA PHARMA INC 0.5%
Value $1.33M Shares 605,300 Est. Cost $4.68 Unrealized
EXEL EXELIXIS INC 0.4%
Value $1.193M Shares 80,000 Est. Cost Unrealized
ALIMERA SCIENCES INC 0.4%
Value $1.052M Shares 974,318 Est. Cost $5.54 Unrealized
LION BIOTECHNOLOGIES INC 0.4%
Value $1.043M Shares 150,000 Est. Cost $7.90 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 0.4%
Value $950K Shares 150,000 Est. Cost $3.99 Unrealized +30.3%
ROCKWELL MED INC 0.3%
Value $917K Shares 140,000 Est. Cost Unrealized
FOLD AMICUS THERAPEUTICS INC 0.3%
Value $722K Shares 145,300 Est. Cost $7.22 Unrealized -4.2%
SPECTRANETICS CORP 0.3%
Value $674K Shares 27,500 Est. Cost $24.51 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 0.2%
Value $627K Shares 99,000 Est. Cost $3.99 Unrealized +30.3%
ARDX ARDELYX INC 0.1%
Value $382K Shares 26,891 Est. Cost $10.59 Unrealized +34.0%
IMMUNOMEDICS INC 0.1%
Value $367K Shares 100,000 Est. Cost $2.70 Unrealized
ASSEMBLY BIOSCIENCES INC 0.0%
Value $122K Shares 10,000 Est. Cost $10.18 Unrealized
ONCOBIOLOGICS INC 0.0%
Value $88,000 Shares 29,082 Est. Cost $3.40 Unrealized
ENDOLOGIX INC 0.0%
Value $86,000 Shares 96,000 Est. Cost $0.90 Unrealized
ONCOBIOLOGICS INC 0.0%
Value $76,000 Shares 96,833 Est. Cost $0.45 Unrealized
MANNKIND CORP 0.0%
Value $58,000 Shares 90,000 Est. Cost Unrealized
PLURISTEM THERAPEUTICS INC 0.0%
Value $30,000 Shares 21,100 Est. Cost Unrealized
ONCOBIOLOGICS INC 0.0%
Value $18,000 Shares 96,833 Est. Cost $0.46 Unrealized
OHR PHARMACEUTICAL INC 0.0%
Value $15,000 Shares 10,000 Est. Cost Unrealized